Literature DB >> 18178151

Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27.

Xiao Ming Feng1, Na Liu, Shao Guang Yang, Li Yan Hu, Xiao Li Chen, Zhi Hong Fang, Qian Ren, Shi Hong Lu, Bin Liu, Zhong Chao Han.   

Abstract

Interleukin-27 (IL-27) is an IL-12-related cytokine that can promote both anti- and pro-inflammatory immune responses. In this study, we used the promonocytic cell line THP-1, an established model for monocytes to investigate if the immunoregulatory role of IL-27 is in part due to effects on major histocompatibility complex (MHC) Ag presentation. We find that IL-27 induces mRNA and surface expression of class II MHC in THP-1 cells. IL-27 also increases class I MHC heavy chain, beta2m, and TAP-1 transcripts, leading to an increased surface expression of class I MHC. In addition, IL-27 enhances expression of costimulatory molecules CD80 and CD86 and adhesion molecule CD54. Expression of the class II transactivator (CIITA) isoforms III and IV, but not I, transcripts increases in response to IL-27. Our data suggest that the pro-inflammatory role of IL-27 is mediated in part through increased expression of key molecules involved in the class II and class I MHC pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178151     DOI: 10.1016/j.bbrc.2007.12.154

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  The presence of interleukin-27 during monocyte-derived dendritic cell differentiation promotes improved antigen processing and stimulation of T cells.

Authors:  Joo-Yong Jung; Lawton L Roberts; Cory M Robinson
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

2.  Interleukin-27 induces a STAT1/3- and NF-kappaB-dependent proinflammatory cytokine profile in human monocytes.

Authors:  Christina Guzzo; Nor Fazila Che Mat; Katrina Gee
Journal:  J Biol Chem       Date:  2010-06-02       Impact factor: 5.157

Review 3.  The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.

Authors:  Xiao-Qing Wei; Helen Rogers; Michael A O Lewis; David W Williams
Journal:  Clin Dev Immunol       Date:  2010-10-24

4.  IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.

Authors:  A Visperas; J S Do; K Bulek; X Li; B Min
Journal:  Mucosal Immunol       Date:  2013-10-16       Impact factor: 7.313

Review 5.  Dual Roles of IL-27 in Cancer Biology and Immunotherapy.

Authors:  Marina Fabbi; Grazia Carbotti; Silvano Ferrini
Journal:  Mediators Inflamm       Date:  2017-02-01       Impact factor: 4.711

6.  Properdin and factor H production by human dendritic cells modulates their T-cell stimulatory capacity and is regulated by IFN-γ.

Authors:  Karen O Dixon; Joseph O'Flynn; Ngaisah Klar-Mohamad; Mohamed R Daha; Cees van Kooten
Journal:  Eur J Immunol       Date:  2017-03       Impact factor: 5.532

Review 7.  Interleukin-27 and Its Diverse Effects on Bacterial Infections.

Authors:  Yugo Morita; Elysia A Masters; Edward M Schwarz; Gowrishankar Muthukrishnan
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

8.  IL-27-induced gene expression is downregulated in HIV-infected subjects.

Authors:  Christina Guzzo; Wilma M Hopman; Nor Fazila Che Mat; Wendy Wobeser; Katrina Gee
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

9.  Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.

Authors:  Andrea Petretto; Grazia Carbotti; Elvira Inglese; Chiara Lavarello; Maria Pia Pistillo; Valentina Rigo; Michela Croce; Luca Longo; Stefania Martini; Paola Vacca; Silvano Ferrini; Marina Fabbi
Journal:  Oncotarget       Date:  2016-11-08

10.  IL-27 amplifies cytokine responses to Gram-negative bacterial products and Salmonella typhimurium infection.

Authors:  C Petes; N Odoardi; S M Plater; N L Martin; K Gee
Journal:  Sci Rep       Date:  2018-09-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.